Dr. Manges is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11050 Parkview Circle Dr
Fort Wayne, IN 46845Phone+1 260-266-7100Fax+1 260-425-6845- Is this information wrong?
Education & Training
University of RochesterFellowship, Hematology and Medical Oncology, 1991 - 1994
Indiana University School of MedicineResidency, Internal Medicine, 1988 - 1991- Indiana University School of MedicineClass of 1988
Certifications & Licensure
IN State Medical License 1989 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer Start of enrollment: 2014 Apr 01
- Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients Start of enrollment: 2014 Mar 08
- Join now to see all
Publications & Presentations
PubMed
- 203 citationsRandomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With...Herbert Hurwitz, Nikhil Uppal, Stephanie Ann Wagner, Johanna C. Bendell, J. Thaddeus Beck
Journal of Clinical Oncology. 2015-09-08 - 128 citationsA phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.Peter M. Voorhees, Robert F. Manges, Pieter Sonneveld, Sundar Jagannath, George Somlo
British Journal of Haematology. 2013-05-01 - 15 citationsSafety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trialGrzegorz S. Nowakowski, Wolfgang Willenbacher, Richard Greil, Thomas Stauffer Larsen, Krish Patel
International Journal of Hematology. 2021-11-19
Professional Memberships
- Member
Hospital Affiliations
Hendricks Regional HealthDanville, Indiana- Fayette Regional Health SystemConnersville, Indiana
- Select Specialty Hospital of INpolisIndianapolis, Indiana
Indiana University Health Bloomington HospitalBloomington, Indiana
Indiana University Health FrankfortFrankfort, Indiana
Ascension St. Vincent Heart CenterIndianapolis, Indiana- Ascension St. Vincent MercyElwood, Indiana
Indiana University Health University HospitalIndianapolis, Indiana
Indiana University Health North HospitalCarmel, Indiana
Indiana University Health West HospitalAvon, Indiana
Parkview HospitalFort Wayne, Indiana- Parkview Wabash HospitalWabash, Indiana
- Parkview Regional Medical CenterFort Wayne, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
